Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-cirrhotic, Chronic Hepatitis B”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Early research (Phase 1)WithdrawnNCT05867056
What this trial is testing

Study of IMC-I109V in Non-cirrhotic HBeAg-negative Chronic HBV Infection

Who this might be right for
Hepatitis B, Chronic
Immunocore Ltd
Early research (Phase 1)Ended earlyNCT02826018
What this trial is testing

ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) Infection

Who this might be right for
Hepatitis BChronic Hepatitis BHepatitis B, Chronic+2 more
Alnylam Pharmaceuticals 24
Not applicableLooking for participantsNCT05195450
What this trial is testing

TAF (Tenofovir Alafenamide) for Preventing Progression of Liver Disease in Non-cirrhotic Chronic HBV Infection With Normal ALT and Low Viral Load.

Who this might be right for
Non-cirrhotic, Chronic Hepatitis B
Institute of Liver and Biliary Sciences, India 200
Testing effectiveness (Phase 2)Study completedNCT02631096
What this trial is testing

Study of ARB-001467 in Subjects With Chronic HBV Infection Receiving Nucleos(t)Ide Analogue Therapy

Who this might be right for
Hepatitis B, Chronic
Arbutus Biopharma Corporation 36
Testing effectiveness (Phase 2)Ended earlyNCT04023721
What this trial is testing

Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic, Hepatitis B e Antigen-negative Subjects Infected With HBV Virus and Receiving or Stopping Treatment With a NUC Inhibitor

Who this might be right for
Hepatitis BHBVHepatitis B, Chronic
F-star Therapeutics, Inc. 64
Post-approval studies (Phase 4)Study completedNCT01277601
What this trial is testing

Efficacy & Safety of Tenofovir Disoproxil Fumarate (TDF) Plus Peginterferon α-2a (Peg-IFN) Versus TDF or Peg-IFN Monotherapy in Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Gilead Sciences 751
Testing effectiveness (Phase 2)Ended earlyNCT04059198
What this trial is testing

Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic Treatment Naive Subjects Infected With Hepatitis B Virus

Who this might be right for
Hepatitis BHBVHepatitis B, Chronic
F-star Therapeutics, Inc. 5